Need professional-grade analysis? Visit stockanalysis.com
$174.05B
838.78
1,412
N/A
ONESOURCE SPECIALTY PHARMA LTD (ONESOURCE) trades on NSE in INR. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at INR1560.70, up 1.11% from the previous close.
Over the past year, ONESOURCE has traded between a low of INR1114.00 and a high of INR1899.90. The stock has lost 16.7% over this period. It is currently 17.9% below its 52-week high.
ONESOURCE SPECIALTY PHARMA LTD has a market capitalization of $174.05B, with a price-to-earnings ratio of 838.78.
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products. The company was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024. OneSource Specialty Pharma Limited was incorporated in 2007 and is based in Bengaluru, India.
Side-by-side comparison against top Healthcare peers.